Actively Recruiting
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
Led by Cedars-Sinai Medical Center · Updated on 2025-06-03
20
Participants Needed
1
Research Sites
516 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary purpose of this study is to evaluate the safety and efficacy of ex vivo machine perfusion with staged implantation of kidney allografts during combined heart/kidney transplantation.
CONDITIONS
Official Title
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (18 years or older) undergoing combined heart and kidney transplantation at Cedars-Sinai Medical Center.
You will not qualify if you...
- Patients who undergo simultaneous heart/kidney transplantation in a single operative event due to medical necessity will be excluded.
- Patients with medical records flagged as "break-the-glass" or "research opt-out" within the center's electronic health record.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
Actively Recruiting
Research Team
J
Justin A Steggerda, M.D.
CONTACT
N
Noriko Ammerman, Pharm.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here